COVID-19 vaccination linked to fewer heart disease events
Vaccination against COVID-19 is linked to fewer heart attacks, strokes, and other heart issues among people who were infected with COVID-19.
Research shows new way to prevent the common cold (and maybe COVID-19)
In a study from Northeastern University, researchers found a new way to prevent the common cold (and maybe COVID-19).
They focused on the crucial question...
COVID-19 survivors may have higher risk of developing diabetes
In a study from Penn State College of Medicine, scientists found COVID-19 survivors have a 66% higher risk of developing type 1 or type...
How COVID-19 can impact heart health
COVID-19 infections can cause potentially life-threatening heart issues.
Studies suggest that people with COVID-19 are 55% more likely to suffer a major adverse cardiovascular event,...
COVID-19 infection increases diabetes risk, study confirms
In a study from Cedars-Sinai, scientists have confirmed that people who have had COVID-19 have an increased risk for new-onset diabetes—the biggest contributor to...
Widely used mental disease drug may reduce COVID-19 symptoms
A recent study from the University of Barcelona found that psychiatric medications can give some protection against COVID-19, with the common antidepressant fluvoxamine showing...
Your 1st COVID-19 vaccination could ‘hurt’ subsequent boosters
In a study from Northwestern Medicine, scientists found the first COVID-19 vaccination could 'hurt' subsequent boosters.
They found the antibodies generated by those prior vaccinations...
Lingering symptoms common after COVID hospitalization
In a study from the University of Michigan, scientists found about half of adults treated at hospitals for COVID-19 have experienced lingering symptoms, financial...
Organ damage in long COVID can be long-lasting
In a study from the UCL Institute of Health Informatics, scientists examined organ impairment in long COVID patients over 12 months.
Why men are at higher risk of COVID-19
Scientists found sex-specific differences in a type of immune cell called regulatory T cells, or "Treg cells," and in the production of proteins called antibodies, as part of the response to COVID-19 infection.